00:00 Introduction to Greg Lucier and His Journey
03:00 Transition from GE to Medical Device Industry
05:49 Lessons Learned at GE
09:07 Embracing Risk and Learning from Failure
11:54 Cultural Adaptation at Invitrogen
14:58 The Evolution of Genomics in Medicine
18:06 Transforming Invitrogen to Life Technologies
21:12 Merging Companies and Creating New Cultures
24:09 Navigating the Financial Crisis and Growth Strategies
27:07 The Sale of Life Technologies
29:59 Taking the Helm at Nuvasive
32:48 Implementing Change and Growth at Nuvasive
43:35 Cultural Transformation and Leadership
46:03 Manufacturing and Globalization Strategies
48:58 Lessons from NuVasive's Growth
52:07 The Future of Spine Surgery
54:54 Navigating Business Ethics in Healthcare
57:05 The Role of People in Business Success
01:00:02 Transitioning to Private Equity and New Ventures
01:03:04 Challenges in the Healthcare Industry
01:07:00 The Future of Corsa Medical
01:09:57 Rapid Fire Questions and Personal Insights
Don’t Let Cybersecurity Risks Delay Your Medical Device Premarket Approval. Check out BlueGoatCyber.com
Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.
Subscribe to our newsletter: https://www.stateofmedtechpodcast.com/
Subscribe to our Youtube Channel
https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg
Follow The State of MedTech on:
- LinkedIn
- Instagram
- TikTok
- X
- Facebook
Follow Omar M. Khateeb on
- LinkedIn
- Instagram
- TikTok
- X
- Facebook
This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.